ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,505,918 | +22.7% | 3,064 | -2.7% | 0.01% | +20.0% |
| Q2 2023 | $1,227,529 | +5.2% | 3,150 | +0.6% | 0.01% | 0.0% |
| Q1 2023 | $1,166,542 | +445.1% | 3,131 | +340.4% | 0.01% | +400.0% |
| Q2 2021 | $214,000 | -27.0% | 711 | -33.1% | 0.00% | 0.0% |
| Q1 2021 | $293,000 | -10.4% | 1,062 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $327,000 | +21.6% | 1,110 | +8.3% | 0.00% | 0.0% |
| Q3 2020 | $269,000 | -18.5% | 1,025 | -29.9% | 0.00% | -50.0% |
| Q2 2020 | $330,000 | +48.6% | 1,462 | +5.7% | 0.00% | +100.0% |
| Q4 2019 | $222,000 | – | 1,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |